Proglumide prevents and curtails acute tolerance to morphine in rats

@article{Tang1984ProglumidePA,
  title={Proglumide prevents and curtails acute tolerance to morphine in rats},
  author={J. Tang and J. Chou and M. Iadarola and H. -. Yang and E. Costa},
  journal={Neuropharmacology},
  year={1984},
  volume={23},
  pages={715-718}
}
  • J. Tang, J. Chou, +2 authors E. Costa
  • Published 1984
  • Psychology, Medicine
  • Neuropharmacology
    • The antagonism of the antinociceptive action of morphine elicited by CCK-8-SO4 can be counteracted by proglumide, a CCK antagonist. The addition of morphine (10(-6)M) to the artificial spinal fluid perfusing the subarachnoidal space of rat spinal cord increases the CCK content of the perfusate. Proglumide can potentiate morphine analgesia without changing the half life of morphine. After seven to eight subcutaneous injections of morphine (4 mg/kg) repeated every two hrs there is tolerance to… CONTINUE READING
    View on Elsevier
    doi.org
    Top 3 of 81 Citations
    The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat.
    C. T. Dourish, M. Oneill, … S. IversenEuropean journal of pharmacology1990
    260
    Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.
    C. T. Dourish, D. Hawley, S. IversenEuropean journal of pharmacology1988
    154
    The role of CCK, caerulein, and CCK antagonists in nociception
    N. Baber, C. T. Dourish, D. R. HillPain1989
    242

    Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    81 Citations
    Citation Type

    Citation Type

    The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat.
    • 260
    Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.
    • 154
    The role of CCK, caerulein, and CCK antagonists in nociception
    • 242
    Mechanisms of opioid-induced tolerance and hyperalgesia.
    • 166
    Cholecystokinin octapeptide (CCK-8): Antagonism to electroacupuncture analgesia and a possible role in electroacupuncture tolerance
    • 131
    Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord.
    • 113
    • Open Access
    The Pharmacology of Pain
    • 143
    • Open Access
    CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat
    • 74
    • Open Access
    Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation
    • 91
    • Open Access
    Opioid and anti‐opioid peptides
    • 136

    References

    Publications referenced by this paper.
    SHOWING 1-9 OF 9 REFERENCES
    Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia.
    • 562
    Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system.
    • 157
    Opiate and peptide interaction: effect of enkephalins on morphine analgesia.
    • 104
    Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cord
    • 147
    Antagonism of morphine-induced catalepsy by L-prolyl-L-leucyl-glycinamide.
    • 47
    Peptide inhibitor of morphine- and beta-endorphin-induced analgesia.
    • 24
    • Open Access
    The effect of peptidase inhibitors on the release of Met5-Enk-Arg6-Phe7 (YGGFMRF) and Met5-enkephalin (YGGFM) from spinal cord induced by substance P in vivo.
    • 14
    Effects of Pro‐Leu‐Gly‐NH2 (MIF) on the antinociceptive and thermoregulatory actions of morphine and oxotremorine
    • 5
    Possible interaction between cholecystokinin and dopamine.
    • 21